| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 275647 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- | 0.0385613993886001 | 0.21427671 |
| NSC 3077 | s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) | 0.0385613993886001 | -0.14070029 |
| NSC 30915 | Null | 0.0385613993886001 | 0.40441315 |
| NSC 328477 | 3'-Chloro-3-nitro-o-salicylotoluidide | 0.0385613993886001 | 0.25662735 |
| NSC 363787 | Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- | 0.0385613993886001 | 0.6275557 |
| NSC 42972 | Null | 0.0385613993886001 | 0.65111679 |
| NSC 47468 | Null | 0.0385613993886001 | 0.39443315 |
| NSC 603578 | Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) | 0.0385613993886001 | 0.24748628 |
| NSC 606499 | Camptothecin Derivative | 0.0385613993886001 | 0.11316552 |
| NSC 614887 | Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) | 0.0385613993886001 | 0.30399184 |